Research reveals a hidden connection between diabetes and cancer. Learn how your blood sugar levels might impact your long-term health.

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

New findings reveal a chilling link between type 2 diabetes and a hidden danger. The truth could change how we see both ...

This finding is especially interesting because Metformin has already been used safely for many years to treat people with ...

A team of scientists has found new clues that could change how we think about aging. Their work suggests that aging might not ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

While the exact mechanism is unknown, the data suggest a multitude of benefits independent of large weight loss.

Researchers report yet another positive finding for GLP-1s. The participants in this trial had lower BMIs than the participants in the many other trials that have shown the benefits of the GLP-1s.

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...